UFPT vs. NVO

Last updated Jun 9, 2026

UFPT (UFP Technologies, Inc.) and NVO (Novo Nordisk A/S) are both stocks. Both are in the Healthcare sector — UFPT in Medical Devices, NVO in Drug Manufacturers - General. Over the past 10 years, UFPT returned 26.04%/yr vs 6.20%/yr for NVO. At a 0.10 correlation, their price movements are largely independent.

Performance

UFPT vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UFP Technologies, Inc. (UFPT) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UFPT achieves a 2.11% return, which is significantly higher than NVO's -16.56% return. Over the past 10 years, UFPT has outperformed NVO with an annualized return of 26.04%, while NVO has yielded a comparatively lower 6.20% annualized return.

UFPT

• 1D: 1.27%
• 1M: -1.67%
• YTD: 2.11%
• 6M: 5.06%
• 1Y: -4.53%
• 3Y*: 10.66%
• 5Y*: 31.64%
• 10Y*: 26.04%

NVO

• 1D: -4.52%
• 1M: -10.96%
• YTD: -16.56%
• 6M: -9.23%
• 1Y: -42.47%
• 3Y*: -17.53%
• 5Y*: 1.78%
• 10Y*: 6.20%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UFPT vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UFPT UFP Technologies, Inc.	2.11%	-9.19%	42.12%	45.93%	67.79%	50.77%	-6.07%	65.15%	8.06%	9.23%
NVO Novo Nordisk A/S	-16.56%	-39.22%	-15.93%	54.84%	22.66%	63.52%	23.33%	28.70%	-12.98%	52.92%

Correlation

The correlation between UFPT and NVO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.21
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.20
Correlation (10Y) Calculated over the trailing 10-year period	0.16
Correlation (All Time) Calculated using the full available price history since Dec 17, 1993	0.10

The correlation between UFPT and NVO shifts across timeframes, from 0.10 (all time) to 0.21 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap UFPT : $1.77B NVO : $182.49B
EPS UFPT : $8.81 NVO : $27.42
PE Ratio UFPT : 25.73 NVO : 1.50
PEG Ratio UFPT : 0.48 NVO : 0.06
PS Ratio UFPT : 2.90 NVO : 0.56
PB Ratio UFPT : 4.03 NVO : 0.90
Total Revenue (TTM) UFPT : $608.85M NVO : $327.80B
Gross Profit (TTM) UFPT : $172.62M NVO : $268.30B
EBITDA (TTM) UFPT : $111.39M NVO : $181.54B

Return for Risk

UFPT vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UFPT

UFPT Risk / Return Rank: 37
UFPT Sharpe Ratio Rank: 38
UFPT Sortino Ratio Rank: 35
UFPT Omega Ratio Rank: 35
UFPT Calmar Ratio Rank: 38
UFPT Martin Ratio Rank: 37

NVO

NVO Risk / Return Rank: 12
NVO Sharpe Ratio Rank: 9
NVO Sortino Ratio Rank: 12
NVO Omega Ratio Rank: 10
NVO Calmar Ratio Rank: 13
NVO Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UFPT vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UFP Technologies, Inc. (UFPT) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UFPT	NVO	Difference
Sharpe ratio: Return per unit of total volatility	-0.10	-0.82	+0.71
Sortino ratio: Return per unit of downside risk	0.16	-1.01	+1.16
Omega ratio: Gain probability vs. loss probability	1.02	0.86	+0.16
Calmar ratio: Return relative to maximum drawdown	-0.15	-0.77	+0.63
Martin ratio: Return relative to average drawdown	-0.27	-1.14	+0.87
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UFPT vs. NVO - Sharpe Ratio Comparison

The current UFPT Sharpe Ratio is -0.10, which is higher than the NVO Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of UFPT and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	UFPT	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.10	-0.82	+0.71
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.72	0.05	+0.67
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.66	0.19	+0.47
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.47	-0.31

Drawdowns

UFPT vs. NVO - Drawdown Comparison

The maximum UFPT drawdown since its inception was -88.53%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for UFPT and NVO.

Drawdown Indicators

	UFPT	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-88.53%	-74.70%	-13.83%
Max Drawdown (1Y) Largest decline over 1 year	-30.69%	-55.03%	+24.34%
Max Drawdown (3Y) Largest decline over 3 years	-48.31%	-74.70%	+26.39%
Max Drawdown (5Y) Largest decline over 5 years	-48.31%	-74.70%	+26.39%
Max Drawdown (10Y) Largest decline over 10 years	-48.31%	-74.70%	+26.39%
Current Drawdown Current decline from peak	-36.75%	-70.19%	+33.44%
Average Drawdown Average peak-to-trough decline	-32.24%	-17.77%	-14.47%
Ulcer Index Depth and duration of drawdowns from previous peaks	16.77%	37.21%	-20.44%

Volatility

UFPT vs. NVO - Volatility Comparison

UFP Technologies, Inc. (UFPT) and Novo Nordisk A/S (NVO) have volatilities of 9.41% and 9.75%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UFPT	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.41%	9.75%	-0.34%
Volatility (6M) Calculated over the trailing 6-month period	30.26%	38.30%	-8.04%
Volatility (1Y) Calculated over the trailing 1-year period	43.47%	52.08%	-8.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.22%	38.31%	+5.91%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	39.62%	32.56%	+7.06%

Dividends

UFPT vs. NVO - Dividend Comparison

UFPT has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.39%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NVO Novo Nordisk A/S	4.39%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%
UFPT UFP Technologies, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

UFPT vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between UFP Technologies, Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

UFPT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported a gross profit of 44.36M and revenue of 154.20M. Therefore, the gross margin over that period was 28.8%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

UFPT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported an operating income of 23.37M and revenue of 154.20M, resulting in an operating margin of 15.2%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

UFPT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported a net income of 17.50M and revenue of 154.20M, resulting in a net margin of 11.4%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

Frequently Asked Questions

Can I hold both UFPT and NVO in my portfolio?

UFPT and NVO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UFPT or NVO?

NVO has higher volatility (9.75%) compared to UFPT (9.41%). In terms of maximum drawdown, UFPT dropped -88.53% vs NVO's -74.70%.

Which has better risk-adjusted returns?

UFPT currently has the higher Sharpe Ratio (-0.10 vs -0.82), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.